Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Prospective Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer

NCT07126626 is registered in ClinicalTrials.gov with Gene Solutions as lead sponsor.

NCT NCT07126626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07126626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Prospective Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer
Lead sponsor
Gene Solutions
Phase
Observational
Overall status
Not yet recruiting
Start date
August 18, 2025
Completion date
July 31, 2027
Enrollment
1,184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer screening, lung diseases